Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety

While immunotherapies, such as CAR T therapy and bi-specific antibodies, have revolutionized the treatment of multiple myeloma (MM), patients with AL amyloidosis have been excluded from trials with these agents due to concerns of underlying autonomic, cardiac, and renal dysfunction, leading to poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Saurav, Ailawadhi, Sikander, Sher, Taimur, Roy, Vivek, Fernandez, Andre, Parrondo, Ricardo D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670199/
https://www.ncbi.nlm.nih.gov/pubmed/37999117
http://dx.doi.org/10.3390/curroncol30110697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670199/
https://www.ncbi.nlm.nih.gov/pubmed/37999117
http://dx.doi.org/10.3390/curroncol30110697

Ejemplares similares